Alpha 1 Antitrypsin Deficiency Aatd Financial Cost
Download Alpha 1 Antitrypsin Deficiency Aatd Financial Cost full books in PDF, epub, and Kindle. Read online free Alpha 1 Antitrypsin Deficiency Aatd Financial Cost ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Azhar ul Haque Sario |
| Publisher | : tredition |
| Total Pages | : 98 |
| Release | : 2024-10-30 |
| Genre | : Medical |
| ISBN | : 3384403282 |
"Alpha-1 Antitrypsin Deficiency (AATD) Financial Cost" provides an in-depth analysis of the financial burdens associated with Alpha-1 Antitrypsin Deficiency (AATD). The book references 14 unique research studies to provide a comprehensive and evidence-based perspective on the financial costs associated with AATD. These studies cover various aspects of medical expenses, including augmentation therapy, hospitalization, emergency care, outpatient care, and the long-term financial impact on patients and families. This research will help people by offering valuable insights into the economic challenges faced by AATD patients and their families. By understanding the financial implications, patients, healthcare providers, and policymakers can make informed decisions about treatment options, insurance coverage, and resource allocation. People care to read this research because it sheds light on the often-overlooked financial aspects of managing a chronic genetic disorder, providing a clearer picture of the true cost of care. The book contributes to the development of healthcare strategies by highlighting the cost-effectiveness of various treatment options and identifying areas where financial support is needed. It brings innovative ideas and research by examining emerging treatments, such as gene therapy and small molecule therapies, and their economic impact. Additionally, the book offers strategies for reducing healthcare costs and improving the overall quality of life for AATD patients. This comprehensive approach makes it a valuable resource for anyone interested in the financial aspects of healthcare and the management of Alpha-1 Antitrypsin Deficiency.
| Author | : Florie Borel |
| Publisher | : Humana Press |
| Total Pages | : 278 |
| Release | : 2017-08-08 |
| Genre | : Science |
| ISBN | : 9781493971619 |
This volume provides protocols that expand on the latest alpha-1-antitrypsin (AAT) research. The chapters in this book are divided in to three sections: Part I is dedicated to patient-oriented research; part II discusses animal models; and Part III focuses on in vitro studies. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Cutting-edge and authoritative, Alpha-1 Antitrypsin Deficiency: Methods and Protocols is a valuable resource for researchers, students, and clinican-scientists interested in AAT deficiency, as well as anyone working in the fields of pulmonology and hepatology.
| Author | : James D. Chalmers |
| Publisher | : European Respiratory Society |
| Total Pages | : 435 |
| Release | : 2018-09-01 |
| Genre | : Medical |
| ISBN | : 1849840989 |
Bronchiectasis is a hot topic in respiratory medicine, attracting an increasing amount of interest from clinicians, scientists, physiotherapists and the pharmaceutical industry. However, there is a lack of knowledge about the disease in terms of the research performed, clinical management, classification and patient treatment. The disease is also very complex because it can be caused by multiple underlying disorders, meaning its clinical presentation is highly diverse. This Monograph will tackle these issues by providing a series of chapters from recognised world experts covering: clinical management, service delivery, pathophysiology, microbiology and underlying disorders. The book also addresses the challenges faced in clinical trials and the need for drug development, and presents a number of clinical cases designed to aid learning. The Bronchiectasis Monograph substantially integrates the 2017 ERS guidelines on management of these patients. It is an essential reference for anyone caring for bronchiectasis patients or engaged in bronchiectasis research.
| Author | : Josephine Mauskopf |
| Publisher | : Springer |
| Total Pages | : 234 |
| Release | : 2017-08-04 |
| Genre | : Medical |
| ISBN | : 3319504827 |
The first of its kind for budget-impact analysis, this comprehensive guide provides clear and concise instructions for evaluating the impact that new pharmaceuticals will have on the budget for a specific jurisdiction. The book demonstrates how to create a budget-impact analysis using a simple six-step process that is consistent with current guidelines for these analyses. Examples and exercises for each chapter afford an opportunity to practice the six-step process in practical applications. The book progresses from a framework for budget impact analyses to an in-depth review of components and how to develop and present these in software applications and reports. Critical considerations such as uncertainty analysis and validation, and considerations for alternate interventions, such as vaccines and diagnostics, are also covered. This book is a “must have” for the builder and budget holder, with builders benefiting from instructions to identify and estimate all necessary variables and budget holders receiving a guide to what should be included in the analyses they assess.
| Author | : Thomas Köhnlein |
| Publisher | : UNI-MED Verlag AG |
| Total Pages | : 106 |
| Release | : 2007 |
| Genre | : Alpha 1-antitrypsin deficiency |
| ISBN | : 1848151152 |
| Author | : Pavel Strnad |
| Publisher | : European Respiratory Society |
| Total Pages | : 211 |
| Release | : 2019-09-01 |
| Genre | : Medical |
| ISBN | : 1849841098 |
This Monograph offers a comprehensive and up-to-date overview of AATD. It covers basic biology, genetics, laboratory diagnostics and the major organ manifestations; describes the clinical presentation of AATD in both adults and children; and features chapters on genetic counselling, patient views and future therapies. The content has been tailored to meet the needs of the physician, who takes care of lung and liver patients in daily practice, and the general practitioner, who is responsible for the medical guidance of these patients.
| Author | : James F. Holland |
| Publisher | : PMPH-USA |
| Total Pages | : 2052 |
| Release | : 2010 |
| Genre | : Medical |
| ISBN | : 9781607950141 |
Holland Frei Cancer Medicine serves as a quick reference to current information on an extensive list of cancers, including breast, lung, thyroid, colorectal, ovarian, prostate, and gastric cancer, to name but a few. Presented as an accessible pocket-sized handbook, the chapters are organized in an outline format, offering only the most essential information on the etiology, staging (including TNM staging) and treatment for each cancer type. Individual chapters are devoted to the molecular biology of cancer, cancer prevention, cancer screening, the mechanisms of chemotherapy, and diagnostic imaging in cancer. Additionally, each chapter lists all the major phase III clinical trials, and therefore, serves as an excellent reference of the major randomized controlled trials for each cancer reported to date. Specific chapters are also dedicated to the discussion of oncologic emergencies, pain and palliation, and prescription complications. At the conclusion of the book, a glossary of oncologic terms and chemotherapeutic drug programs, a table of common cancer incidences, and an overview of the mechanisms, common uses, and related toxicities of various anti-cancer agents are featured. In addition, performance status tables, mathematical formulas and a listing of common biomedical / cancer web sites are highlighted.
| Author | : Manuel Posada de la Paz |
| Publisher | : Springer |
| Total Pages | : 675 |
| Release | : 2017-12-06 |
| Genre | : Medical |
| ISBN | : 3319671448 |
The fields of rare diseases research and orphan products development continue to expand with more products in research and development status. In recent years, the role of the patient advocacy groups has evolved into a research partner with the academic research community and the bio-pharmaceutical industry. Unique approaches to research and development require epidemiological data not previously available to assist in protocol study design and patient recruitment for clinical trials required by regulatory agencies prior to approval for access by patents and practicing physicians.
| Author | : Vincent Cottin |
| Publisher | : Springer |
| Total Pages | : 623 |
| Release | : 2015-01-10 |
| Genre | : Medical |
| ISBN | : 1447124014 |
Orphan Lung Diseases: A Clinical Guide to Rare Lung Disease provides a comprehensive, clinically focused textbook on rare and so-called ‘orphan’ pulmonary diseases. The book is oriented towards the diagnostic approach, including manifestations suggesting the disease, diagnostic criteria, methods of diagnostic confirmation, and differential diagnosis, with an overview of management.
| Author | : Kian Fan Chung |
| Publisher | : European Respiratory Society |
| Total Pages | : 365 |
| Release | : 2019-06-01 |
| Genre | : Medical |
| ISBN | : 1849841047 |
Severe asthma is a form of asthma that responds poorly to currently available medication, and its patients represent those with greatest unmet needs. In the last 10 years, substantial progress has been made in terms of understanding some of the mechanisms that drive severe asthma; there have also been concomitant advances in the recognition of specific molecular phenotypes. This ERS Monograph covers all aspects of severe asthma – epidemiology, diagnosis, mechanisms, treatment and management – but has a particular focus on recent understanding of mechanistic heterogeneity based on an analytic approach using various ‘omics platforms applied to clinically well-defined asthma cohorts. How these advances have led to improved management targets is also emphasised. This book brings together the clinical and scientific expertise of those from around the world who are collaborating to solve the problem of severe asthma.
